These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34592197)

  • 1. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: In silico analysis and validation.
    Nazempour N; Taleqani MH; Taheri N; Haji Ali Asgary Najafabadi AH; Shokrollahi A; Zamani A; Fattahi Dolatabadi N; Peymani M; Mahdevar M
    Exp Mol Pathol; 2021 Dec; 123():104688. PubMed ID: 34592197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity.
    Amani MS; Peymani M
    Mol Biol Rep; 2024 Jul; 51(1):831. PubMed ID: 39037563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
    Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
    Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
    Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
    J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer.
    Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E
    Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivity.
    Hashemi R; Peymani M; Ghaedi K; Saffar H
    Med Oncol; 2022 Feb; 39(5):57. PubMed ID: 35150347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer.
    Ren Y; Deng R; Cai R; Lu X; Luo Y; Wang Z; Zhu Y; Yin M; Ding Y; Lin J
    Carcinogenesis; 2020 Dec; 41(12):1755-1766. PubMed ID: 32338281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers.
    Golozar M; Motlagh AV; Mahdevar M; Peymani M; InanlooRahatloo K; Ghaedi K
    Exp Mol Pathol; 2024 Apr; 136():104890. PubMed ID: 38378070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
    Xiong Y; You W; Wang R; Peng L; Fu Z
    Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Profiling Identifies
    Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
    Front Immunol; 2021; 12():722807. PubMed ID: 34646265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
    Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
    J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.
    Shi Q; He Y; Zhang X; Li J; Cui G; Zhang X; Wang X
    Med Sci Monit; 2019 Sep; 25():7042-7051. PubMed ID: 31536481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C
    BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer.
    Shi D; Zheng H; Zhuo C; Peng J; Li D; Xu Y; Li X; Cai G; Cai S
    Med Oncol; 2014 Jul; 31(7):31. PubMed ID: 24908062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.